loadpatents
Patent applications and USPTO patent grants for THOM; Stephen Malcolm.The latest application filed is for "itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response".
Patent | Date |
---|---|
Itaconic Acid Derivatives And Uses Thereof Intreating An Inflammatory Disease Or A Disease Associated With An Undesirable Immune Response App 20220265595 - COOKE; Michael Liam ;   et al. | 2022-08-25 |
Kinase inhibitors Grant 10,941,115 - Baker , et al. March 9, 2 | 2021-03-09 |
Kinase Inhibitors App 20190330155 - BAKER; Thomas Matthew ;   et al. | 2019-10-31 |
Kinase inhibitors Grant 10,442,828 - Fyfe , et al. Oc | 2019-10-15 |
Kinase inhibitors Grant 10,435,361 - Baker , et al. O | 2019-10-08 |
Kinase inhibitors Grant 10,392,346 - Baker , et al. A | 2019-08-27 |
Kinase inhibitors Grant 10,125,100 - Baker , et al. November 13, 2 | 2018-11-13 |
Kinase Inhibitors App 20180319748 - BAKER; Thomas Matthew ;   et al. | 2018-11-08 |
Kinase Inhibitors App 20180305383 - FYFE; Matthew Colin Thor ;   et al. | 2018-10-25 |
Kinase inhibitors Grant 10,072,034 - Fyfe , et al. September 11, 2 | 2018-09-11 |
Kinase Inhibitors App 20180044288 - BAKER; Thomas Matthew ;   et al. | 2018-02-15 |
Urea derivatives useful as kinase inhibitors Grant 9,890,185 - Fyfe , et al. February 13, 2 | 2018-02-13 |
Kinase inhibitors Grant 9,796,742 - Fyfe , et al. October 24, 2 | 2017-10-24 |
Kinase inhibitors Grant 9,790,174 - Thom October 17, 2 | 2017-10-17 |
Kinase inhibitors Grant 9,790,209 - Fyfe , et al. October 17, 2 | 2017-10-17 |
Kinase Inhibitors App 20170291917 - FYFE; Matthew Colin Thor ;   et al. | 2017-10-12 |
Kinase inhibitors Grant 9,783,556 - Fyfe , et al. October 10, 2 | 2017-10-10 |
Kinase Inhibitors App 20170253563 - BAKER; Thomas Matthew ;   et al. | 2017-09-07 |
Kinase inhibitors Grant 9,751,837 - Baker , et al. September 5, 2 | 2017-09-05 |
Kinase inhibitors Grant 9,732,063 - Frickel , et al. August 15, 2 | 2017-08-15 |
Pyrazolyl-ureas as kinase inhibitors Grant 9,701,670 - Cariou , et al. July 11, 2 | 2017-07-11 |
Kinase Inhibitors App 20160376232 - Thom; Stephen Malcolm | 2016-12-29 |
Kinase Inhibitors App 20160340375 - FYFE; Matthew Colin Thor ;   et al. | 2016-11-24 |
Kinase Inhibitors App 20160340343 - FYFE; Matthew Colin Thor ;   et al. | 2016-11-24 |
Urea Derivatives Useful As Kinase Inhibitors App 20160318958 - Fyfe; Matthew Colin Thor ;   et al. | 2016-11-03 |
Kinase inhibitors Grant 9,481,648 - Baker , et al. November 1, 2 | 2016-11-01 |
Kinase Inhibitors App 20160102059 - BAKER; Thomas Matthew ;   et al. | 2016-04-14 |
Kinase Inhibitors App 20150329523 - FRICKEL; Fritz-Frieder ;   et al. | 2015-11-19 |
Kinase Inhibitors App 20150225373 - Fyfe; Matthew Colin Thor ;   et al. | 2015-08-13 |
Kinase Inhibitors App 20150225427 - Fyfe; Matthew Colin Thor ;   et al. | 2015-08-13 |
Pyrazolyl-ureas As Kinase Inhibitors App 20150218137 - Cariou; Claire Anne Marie ;   et al. | 2015-08-06 |
Kinase Inhibitors App 20150210722 - Fyfe; Matthew Colin Thor ;   et al. | 2015-07-30 |
Kinase Inhibitors App 20140296208 - BAKER; Thomas Matthew ;   et al. | 2014-10-02 |
Kinase Inhibitors App 20140057915 - CARIOU; CLAIRE ANNE MARIE ;   et al. | 2014-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.